-+ 0.00%
-+ 0.00%
-+ 0.00%

LABCORP HOLDINGS - PLASMA DETECT NOW AVAILABLE FOR CLINICAL USE TO ASSESS RISK OF RECURRENCE IN STAGE III COLON CANCER PATIENTS

Reuters·04/23/2025 11:00:07

Please log in to view news